About Symbionic
Symbionic is a Healthcare company based in Chennai (India) founded in 2019 by Niranjan Kumar and Rishi Krishna. It operates as a prosthetic arms are manufactured for comfort and ease of use. It operates in the Healthcare and Technology sectors. Symbionic has raised $5.39 million across 8 funding rounds from investors including GoFrugal Technologies, StartupTN and iThought. Symbionic was last valued at $1.03 million in March 2022. Its chief executive is Rishi Krishna. Its Indian entity Symbionic Tech Private Limited reported revenue of ₹41.9 Lakh. Symbionic offers products and services including Krea Adaptive, Krea Cosmetic, Krea Ride Assist, Krea Swim Assist, and Krea Gym Assist. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Myomo, Proteor, BionicM, CIONIC and Epica International and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Symbionic was founded in 2019 in Chennai, India, as a manufacturer in the medical prosthetics sector. Prosthetic arms are produced with modular designs that support component replacement and integration into clinical systems, reducing operational downtime. Functional and cosmetic options are offered to support patient independence in daily activities. Operations focus on reliable manufacturing processes within the healthcare industry.
- Headquarters Chennai, India
- Founders Niranjan Kumar, Rishi Krishna
- Stage Minicorn
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website symbionic.co
- Social LinkedIn X Facebook Instagram
- Legal Name Symbionic Tech Private Limited
- Date of Incorporation 31 Oct, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹41.9 Lakh
FY 2025 · -23% YoY
- Net Loss-₹1.56 Cr
FY 2025 · -373% margin
- EBITDA-₹1.07 Cr
FY 2025 · -256% margin
- Total Equity Funding$5.39M (USD)
in 8 rounds
- Latest Funding Round$46.8K (USD), Angel Round
Apr 2025
- InvestorsGoFrugal Technologies
& 11 more
Associated legal entities of Symbionic
Symbionic operates through Symbionic Tech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Symbionic Tech Private Limited CIN U33309TN2019PTC132332 | Active | 31 Oct 2019 | Chennai, Tamil Nadu | ₹0.4 Cr | – | 2 | View details |
Products & Services of Symbionic
Symbionic offers a comprehensive portfolio of products and services, including Krea Adaptive, Krea Cosmetic, Krea Ride Assist, Krea Swim Assist, and Krea Gym Assist.
Comfortable prosthetic for everyday use by amputees.
Enhances confidence for amputees in daily life.
Assists amputees with ease during riding activities.
Enables safe swimming for upper-limb amputees.
Supports physical exercises for amputees in gyms.
Funding Insights of Symbionic
Symbionic has successfully raised a total of $5.39M across 8 strategic funding rounds. The most recent funding activity was a Angel Round of $46.8 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.39M
- Total Rounds 8
- Last Round Angel Round — $46,796
- First Round $40,887
(Mar 2021)
- Investors Count 12
All 8 funding rounds of Symbionic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $46,796 | Debt – Conventional | – | – | |
| Apr 2025 | $46,796 | Angel Round | – | Namita Thapar | – |
| Mar 2025 | $4.63M | Angel Round | – | – | |
| Mar 2025 | $4.63M | Debt – Conventional | – | – | – |
| Jun 2023 | $487,456 | Seed | – | Gofrugal | |
| Nov 2022 | – | Grant | – | – | |
| Mar 2022 | $177,972 | Seed | $1.03M | Bipin Vazirani Family Trust | |
| Mar 2021 | $40,887 | Seed | $820,545 | BIRAC, VIT-TBI | – |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2022 | $1.03M | •••••••• |
Last known valuation $1.03M (Mar 2022). 11 investors in total: 6 institutional and 5 angel.
Investors in Symbionic
Symbionic has secured backing from 11 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include GoFrugal Technologies, StartupTN and iThought.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Potato farming, grain marketing, and equipment services in Maine. | 2021 | startuptn.in | Chennai, India | |
Multiple investments are managed by this single-family office. | – | bipinvaziranifamilytrust.tcc.mode | Mumbai, India | |
Business incubation services are provided across multiple sectors. | – | birac.nic.in | Delhi, India | |
Technology business incubation and support services for innovators are provided in India. | 2003 | vittbi.com | Vellore, India | |
Offers portfolio management and financial planning for individual investors. | 2011 | ithought.co.in | Chennai, India | |
Offers ERP solutions for retail, restaurant, and distribution operations. | 2004 | gofrugal.com | Chennai, India | |
NJ Nehal Jagat Parikh | - | – | unknown_7d78fea345024796b | - |
NT Namita Thapar | Executive Director at Emcure Pharmaceuticals, angel investor, Shark Tank India judge | – | unknown_8ab51537079a4c57b | - |
RM Ramesh Mangaleswaran | - | – | unknown_906487966d2e4dcdb | - |
KJ KRS Jamwal | - | – | unknown_39ce5c90ea9a4c28a | - |
Investor details for Symbionic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Symbionic Tech Private Limited (Symbionic)
Symbionic Tech Private Limited is the primary company behind Symbionic. The board of Symbionic Tech Private Limited currently have 2 directors; the longest-serving is Niranjankumar Raghupathi, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Niranjankumar Raghupathi DIN 08600225 | Director | 31 Oct 2019 | 6 yrs 11 mo | Symbionic Tech Private Limited |
| Rishi Krishna Iyer Suresh DIN 08600223 | Director | 31 Oct 2019 | 6 yrs 11 mo | Symbionic Tech Private Limited |
People of Symbionic
2 people are tracked at Symbionic (2 in leadership).
| Name | Role | Group |
|---|---|---|
Niranjan Kumar | Co-Founder & CTO | Leadership |
| Co-Founder & CEO | Leadership |
Complete people profiles for Symbionic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Symbionic
Figures of Symbionic Tech Private Limited, the primary company behind Symbionic, for FY 2025. Revenue was ₹41.9 Lakh (-23% year on year). Net loss was -₹1.56 Cr (-373% margin). EBITDA was -₹1.07 Cr (-256% margin). Revenue has grown at a compounded annual rate of +43% over five years.
- ₹41.9 LakhRevenue · FY 2025 · -23% YoY
- -₹1.56 CrNet loss · -373% margin
- -₹1.07 CrEBITDA · -256% margin
- ₹1.6 LakhPaid-up capital
- +43%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Symbionic Tech Private Limited are on its company page.
Detailed financial statements for Symbionic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Symbionic
4 dated milestones of Symbionic across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Symbionic is founded.
- Funding First funding round of $41K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $47K.
Competitors of Symbionic
Symbionic has 10 listed competitors in our database, 8 of them funded. They include Myomo, Proteor, BionicM, CIONIC and Epica International, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| myomo.com | 2004 | Boston, United States | $17.21M | 80 | Robotic arms are provided for mobility and rehabilitation support. | |
| proteor.com | 1913 | Dijon, France | – | – | Prostheses and orthoses devices are developed for orthopedic supports. | |
| bionicm.com | 2016 | Tokyo, Japan | $11.03M | – | Prosthetic legs assisting knee and ankle movements are developed. | |
| cionic.com | 2018 | Scotts Valley, United States | $32.25M | 34 | Bionic clothing is provided for mobility impairment support. | |
| epicainternational.com | 2014 | San Clemente, United States | $25.7M | – | Provider of robotic CT platforms for healthcare and industrial applications | |
| kinovarobotics.com | 2006 | Boisbriand, Canada | $57M | – | Robotic arms are developed for personal assistance and research. | |
| bioliberty.co.uk | 2020 | Edinburgh, United Kingdom | $2.72M | 14 | Provides robotic assistance gloves for managing hand weakness. | |
| reev.care | 2021 | Toulouse, France | $12.44M | – | AI-powered exoskeletons and gait tools are developed for mobility recovery. | |
| atomlimbs.com | 2019 | San Francisco, United States | – | – | AI-powered prosthetics restore physical abilities for users worldwide. | |
| psyonic.io | 2015 | Champaign, United States | $1.18M | 21 | Bionic limbs are developed for individuals with amputations. |
Detailed competitors of Symbionic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Symbionic
The website of Symbionic (symbionic.co) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 2% vs previous month
Top companies in Orthopedics
10 companies that operate in the same segment as Symbionic (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Symbionic
Complete news archive for Symbionic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symbionic
Symbionic was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Symbionic is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Rishi Krishna is the current CEO of Symbionic. They have also founded this company.
Symbionic is a funded company, having raised a total of $5.39M across 8 funding rounds to date. The company's 1st funding round was a Seed of $40.89K, raised on Mar 2021.
The primary company behind Symbionic, Symbionic Tech Private Limited, reported revenue of ₹41.9 Lakh for FY 2025, down 23% year on year.
Symbionic was founded in 2019 in Chennai, India, as a manufacturer in the medical prosthetics sector. Prosthetic arms are produced with modular designs that support component replacement and integration into clinical systems, reducing operational downtime. Functional and cosmetic options are offered to support patient independence in daily activities. Operations focus on reliable manufacturing processes within the healthcare industry.
Symbionic's top competitors include Myomo, BionicM and Epica International.
Symbionic offers Krea Adaptive, Krea Cosmetic, Krea Ride Assist, Krea Swim Assist, and Krea Gym Assist.
Symbionic has 11 investors. Key investors include GoFrugal Technologies, StartupTN, iThought, VIT-TBI, and Bipin Vazirani Family Trust.
The valuation of Symbionic is $1.03M as of Mar 2022.
Symbionic operates through Symbionic Tech Private Limited.
The legal entities of Symbionic currently have 2 directors, including Niranjankumar Raghupathi, Rishi Krishna Iyer Suresh.